Nivolumab in Combination With Talazoparib in Melanoma and Mutations in BRCA or BRCA-ness Genes
Clinical trial NCT04187833 · COMPLETED
Trial details
- NCT number
- NCT04187833
- Sponsor
- Case Comprehensive Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-05
- Primary completion
- 2023-10-13
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.